Fortress Biotech, Inc. (FBIO)
2.52
-0.05
(-1.95%)
USD |
NASDAQ |
Sep 11, 16:00
2.535
+0.02
(+0.60%)
After-Hours: 20:00
Fortress Biotech Price to Book Value : 0.5114 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.5114 |
| September 10, 2026 | 0.5216 |
| September 09, 2026 | 0.5337 |
| September 08, 2026 | 0.55 |
| September 04, 2026 | 0.552 |
| September 03, 2026 | 0.55 |
| September 02, 2026 | 0.554 |
| September 01, 2026 | 0.5439 |
| August 31, 2026 | 0.5551 |
| August 28, 2026 | 0.5622 |
| August 27, 2026 | 0.5682 |
| August 26, 2026 | 0.5703 |
| August 25, 2026 | 0.5743 |
| August 24, 2026 | 0.5946 |
| August 21, 2026 | 0.5825 |
| August 20, 2026 | 0.5622 |
| August 19, 2026 | 0.5784 |
| August 18, 2026 | 0.5906 |
| August 17, 2026 | 0.5723 |
| August 14, 2026 | 0.5946 |
| August 13, 2026 | 0.6048 |
| August 12, 2026 | 0.5581 |
| August 11, 2026 | 0.5297 |
| August 10, 2026 | 0.5581 |
| August 07, 2026 | 0.5419 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.5622 |
| August 05, 2026 | 0.5662 |
| August 04, 2026 | 0.552 |
| August 03, 2026 | 0.5601 |
| July 31, 2026 | 0.6352 |
| July 30, 2026 | 0.6677 |
| July 29, 2026 | 0.6799 |
| July 28, 2026 | 0.688 |
| July 27, 2026 | 0.6636 |
| July 24, 2026 | 0.6778 |
| July 23, 2026 | 0.6961 |
| July 22, 2026 | 0.7205 |
| July 21, 2026 | 0.7164 |
| July 20, 2026 | 0.6758 |
| July 17, 2026 | 0.6819 |
| July 16, 2026 | 0.6941 |
| July 15, 2026 | 0.7529 |
| July 14, 2026 | 0.757 |
| July 13, 2026 | 0.6697 |
| July 10, 2026 | 0.6697 |
| July 09, 2026 | 0.6677 |
| July 08, 2026 | 0.6088 |
| July 07, 2026 | 0.6068 |
| July 06, 2026 | 0.5987 |
| July 02, 2026 | 0.617 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 23.55 |
| Kura Oncology, Inc. | 20.92 |
| Spero Therapeutics, Inc. | 1.486 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
Price to Book Value Related Metrics
| PE Ratio | 0.9486 |
| PS Ratio | 1.239 |
| Price to Free Cash Flow | 0.7054 |
| Price | 2.52 |
| Earnings Yield | 105.4% |
| Market Cap | 83.94M |
| Normalized PE Ratio | 1.029 |